Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$19,631,687
+$320,880 QoQ
Shares Held
125,266
-0.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#120
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $1,296,853,654 across 14 Drug Manufacturers - General names. NVS ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
347,098 | $416,319,788 | |
| 2 | ABBV |
AbbVie Inc.
|
1,287,857 | $324,076,335 | |
| 3 | JNJ |
Johnson & Johnson
|
956,262 | $242,861,860 | |
| 4 | MRK |
Merck & Co., Inc.
|
920,715 | $118,311,877 | |
| 5 | AMGN |
Amgen Inc
|
150,777 | $54,599,367 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
272,940 | $34,483,239 | |
| 7 | PFE |
Pfizer Inc
|
1,406,138 | $33,859,803 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
416,247 | $23,984,152 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,631,687 | 125,266 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,310,807 | 126,421 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $11,205,797 | 81,278 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,428,702 | 65,726 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,999,608 | 66,107 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $8,530,672 | 76,522 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,809,322 | 80,252 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $9,295,801 | 80,819 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,640,506 | 81,162 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,930,409 | 81,985 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,607,793 | 85,251 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $8,626,625 | 84,691 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,777,454 | 86,983 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,166,288 | 88,764 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,230,118 | 90,720 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,513,588 | 98,850 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $8,364,243 | 98,950 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $8,789,478 | 100,165 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,838,756 | 101,049 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,421,126 | 90,745 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,713,511 | 95,501 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,109,750 | 129,969 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $14,486,789 | 153,413 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $18,228,294 | 209,617 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $17,166,851 | 196,552 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $17,268,740 | 209,445 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||